reports
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Mer...
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel Luxembourg, August 14, 2025 – Millicom (Tigo) today announced a key agreement with Empresas Públicas de Medellín (EPM) that advances its acquisition strategy in Colombia and unlocks a path toward the integration of Tigo-UNE and Colombia Telecomunicaciones (ColTel). Under the terms of the agreement: Millicom has committed to present an offer in EPM’s Law 226 sale process, subject to the terms published b...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Capital Increase in Genmab as a Result of Employee Warrant Exercise Company Announcement COPENHAGEN, Denmark; August 12, 2025 – (Nasdaq: GMAB) will increase its share capital by 4,563 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 2,580 shares at DKK 1,025.00,1,874 shares at DKK 1,050.00, and109 shares at DKK 1,161.00. Proceeds to the company are approximately DKK 4.7 million....
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Oil & Oil Services Research
- Njål Kleiven
- Stian Wibstad
Genmab Announces Financial Results for the First Half of 2025
Genmab Announces Financial Results for the First Half of 2025 August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epcoritamab plus R2 in patients with relapsed or refractory FLRinatabart sesutecan (Rina-S®) continues to progress, demonstrating encouraging antitumor activity in endometrial cancer in data presented at the 2025 ASCO Annual MeetingData from over 40 abstracts highlighting the depth, breadth and strength of Genmab’s comprehensive epcori...
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary ...
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival (HR 0.21, p-value
Millicom (Tigo) Q2 2025 Earnings Release
Millicom (Tigo) Q2 2025 Earnings Release Millicom (Tigo) Q2 2025 Earnings Release Luxembourg, August 7, 2025 – is pleased to announce its second quarter 2025 results. Please find below links to the Q2 2025 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Q2 2025 Highlights* Revenue $1.37 billion Operating profit $357 million, and record Adjusted EBITDA $641 million Net profit $676 million, including approximately $590 million net profit from infrastructure transactions Equity free cash flow $218 million Leverage of 2.18x, benefiting from one-time c...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Oil & Oil Services Research
- Njål Kleiven
- Stian Wibstad
Millicom (Tigo) declares $2.50 per share interim dividend to be paid i...
Millicom (Tigo) declares $2.50 per share interim dividend to be paid in two equal installments on October 15, 2025 and April 15, 2026 Luxembourg, August 6, 2025 – In line with the press release published on June 13, 2025, the Board of Directors of Millicom International Cellular S.A. (“Millicom”) approved the interim dividend of $2.50 per share, to be paid in two equal installments of $1.25 per share on October 15, 2025 and April 15, 2026. Other important dates and information relating to the Interim Dividend are as follows: First Installment Interim Dividend Payment First Installment Int...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
Transocean Ltd. Reports Second Quarter 2025 Results
Transocean Ltd. Reports Second Quarter 2025 Results Three months ended Three months ended June 30,2025 March 31,2025 sequentialchange June 30,2024 year-over-yearchange(In millions, except per share amounts, percentages and backlog) Contract drilling revenues$988 $906 $82 $861 $127 Revenue efficiency (1) 96.6 % 95.5 % 96.9 % Operating and maintenance expense$599 $618 $19 $534 $(65)Net loss attributable to controlling interest$(938) $(79) $(859) $(123) $(815)Basic loss per share$(1.06) $(0.09) $(0.97) $(0.15) $(0.91)...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- Delphine Chauvin
Securitas : Evolution of coverage
As part of the rotation of our coverage, we are terminating the coverage with recommendation of Securitas. We will continue to follow the newsflow of the issuer in the Credit Morning. Our previous credit opinion was Positive and our previous market recommendations were Buy on SECUSS 2027 & 2029 and Neutral on SECUSS 2028 bonds. We plan to initiate the coverage of new issuers soon.
- Delphine Chauvin
Securitas : Evolution de la couverture
Dans le cadre de la rotation du suivi de nos valeurs, nous arrêtons la couverture avec recommandation de Securitas. Nous continuerons de suivre le newsflow de cet émetteur dans le Morning crédit. Notre précédent avis crédit était Positif et nos précédentes recommandations de marché étaient Achat sur les obligations SECUBSS 2027 et 2029 et Neutre sur la souche 2028. Nous comptons prochainement initier la couverture de nouveaux émetteurs.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.